1-800-526-8630
1 of 5
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates
Summary
In 2015, the UAE population was approximately at 9.6 million. The government of the UAE has been making continuous efforts to strengthen the economy to ensure long-term growth, and the pharmaceutical market is seen as a key industry for the country’s future growth. To support this industry, the government has improved regulatory guidelines and initiatives to develop the domestic pharmaceutical market. The UAE pharmaceutical market is the second-largest pharmaceutical market in the Gulf Cooperation Council (GCC) after Saudi Arabia. The Pharmaceutical market was estimated to be worth $3.05 billion in 2015 and expected to reach $5.71 billion by 2020. The market grew nominally at a Compound Annual Growth Rate (CAGR) of 13.4% over the 2008-2020 period. The medical device market was valued at $664m in 2008 and is expected to reach approximately $810m by 2020, at a projected CAGR of 4.1%.
These positive trends can primarily be attributed to -
- Growing medical tourism, healthcare infrastructure, expanding health insurance and increasing health expenditure
- Increasing awareness in the medical community and the general population regarding early disease detection and diagnosis, leading to higher rates of adoption of treatments and healthcare
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in the UAE, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Julphar, Neopharma, Pfizer, GlaxoSmithKline, Novartis)
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the UAE healthcare market
Reasons to buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the UAE healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the UAE healthcare market
READ MORE
Summary
In 2015, the UAE population was approximately at 9.6 million. The government of the UAE has been making continuous efforts to strengthen the economy to ensure long-term growth, and the pharmaceutical market is seen as a key industry for the country’s future growth. To support this industry, the government has improved regulatory guidelines and initiatives to develop the domestic pharmaceutical market. The UAE pharmaceutical market is the second-largest pharmaceutical market in the Gulf Cooperation Council (GCC) after Saudi Arabia. The Pharmaceutical market was estimated to be worth $3.05 billion in 2015 and expected to reach $5.71 billion by 2020. The market grew nominally at a Compound Annual Growth Rate (CAGR) of 13.4% over the 2008-2020 period. The medical device market was valued at $664m in 2008 and is expected to reach approximately $810m by 2020, at a projected CAGR of 4.1%.
These positive trends can primarily be attributed to -
- Growing medical tourism, healthcare infrastructure, expanding health insurance and increasing health expenditure
- Increasing awareness in the medical community and the general population regarding early disease detection and diagnosis, leading to higher rates of adoption of treatments and healthcare
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in the UAE, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Julphar, Neopharma, Pfizer, GlaxoSmithKline, Novartis)
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the UAE healthcare market
Reasons to buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the UAE healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the UAE healthcare market
Note: Product cover images may vary from those shown
2 of 5
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Report Guidance
3 Overview of Pharmaceutical and Medical Device Markets
3.1 Pharmaceutical Market
3.1.1 Market Overview
3.1.2 Pharmaceutical Imports and Exports
3.1.3 Supply Channels
3.1.4 Market Segments
3.1.5 Major Therapeutic Areas
3.1.6 Major Players
3.2 Medical Device Market
3.2.1 Market Overview
3.2.2 Overview of the Top Five Segments
3.2.3 Major Players
3.3 Market Drivers and Barriers
3.3.1 Drivers
3.3.2 Barriers
4 Market Access
4.1 Reimbursement and Payer Landscape
4.1.1 Overview of Healthcare System
4.1.2 Reimbursement Process
4.1.3 Overview of Insurance Providers
4.1.4 Patient Share of Healthcare Expenditure
4.1.5 Healthcare Price Trends
4.1.6 Pricing Policies
4.2 Regulatory Landscape
4.2.1 Overview of Regulatory Agencies
4.2.2 Market Authorization Procedure for Pharmaceutical Products
4.2.3 New Medical Device Approval Process
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing
4.2.5 Licensing Process for Pharmaceutical Exports and Imports
4.2.6 Intellectual Property Rights
4.2.7 Clinical Trial Regulations
4.2.8 Pharmaceutical Advertising Regulations
4.2.9 Pharmacy Regulations
4.2.10 Labeling and Packaging Regulations
5 Country Analysis
5.1 Political Environment
5.1.1 Political Structure
5.1.2 Analysis of the Current Political Environment
5.1.3 Healthcare Policy Initiatives
5.2 Economic Landscape
5.3 Economic Indicators
5.3.1 Gross Domestic Product
5.3.2 Gross National Income
5.3.3 Inflation
5.3.4 Currency Exchange Rate
5.3.5 Foreign Direct Investment
5.3.6 Foreign Exchange Reserves
5.3.7 Trade Balance
5.3.8 Government Net Debt
5.3.9 Major Industries
5.4 Demographics
5.4.1 Population
5.4.2 Education and Literacy
5.4.3 Employment
5.4.4 Disease Burden
5.5 Healthcare Infrastructure
5.5.1 Healthcare Facilities
5.5.2 Healthcare Parameters
5.5.3 Environmental Health
5.5.4 Healthcare Personnel
5.6 Healthcare Expenditure
5.6.1 Overview of Healthcare Expenditure
5.6.2 Major Components of Healthcare Expenditure
5.6.3 Public and Private Sector Share
5.6.4 Spending in Pharmaceutical R&D
5.7 Trade Associations
5.7.1 Arab Union of Producers of Drugs and Medical Supplies
5.7.2 Emirates Medical Association
5.7.3 Pharmaceutical Research and Manufacturers Association Gulf
5.7.4 Gulf Pharmaceutical Industries Association
5.7.5 Middle East Medical Devices and Diagnostics Trade Association
5.8 Trade Fairs
6 Opportunities and Challenges
6.1 Opportunities
6.2 Challenges
7 Appendix
7.1 Abbreviations
7.2 Bibliography
7.3 Research Methodology
7.3.1 Coverage
7.3.2 Secondary Research
7.3.3 Forecasts
7.3.4 Expert Panel
7.4 Disclaimer
1.1 List of Tables
Table 1: Pharmaceutical Market, UAE, Revenue ($bn), 2008-2015
Table 2: Pharmaceutical Market, UAE, Revenue Forecast ($bn), 2016-2020
Table 3: Pharmaceutical Market, UAE, Imports and Exports ($m), 2008-2014
Table 4: Pharmaceutical Market, Julphar, Global, Major Products, 2016
Table 5: Pharmaceutical Market, Neopharma, Global, Major Products, 2016
Table 6: Pfizer, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015
Table 7: Pharmaceutical Market, Pfizer, Late-Stage Pipeline, 2016
Table 8: GlaxoSmithKline, Global, Major Products Revenue ($m) and Annual Growth (%), 2015
Table 9: Pharmaceutical Market, GlaxoSmithKline, Late-Stage Pipeline, 2016
Table 10: Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015
Table 11: Pharmaceutical Market, Novartis, Planned Filings, 2014-2018
Table 12: Medical Device Market, UAE, Revenue ($m), 2008-2015
Table 13: Medical Device Market, UAE, Revenue ($m), 2016-2020
Table 14: Medical Device Market, UAE, Revenue by Segment ($m), 2015
Table 15: Medical Device Market, UAE, In Vitro Diagnostics Market, Revenue ($m), 2008-2015
Table 16: Medical Device Market, UAE, In Vitro Diagnostics Market, Sales Trend for Major Players, 2012
Table 17: Medical Device Market, UAE, Ophthalmic Devices Market, Revenue ($m), 2008-2015
Table 18: Medical Device Market, UAE, Ophthalmic Devices Market, Sales Trend for Major Players, 2012
Table 19: Medical Device Market, UAE, Orthopedic Devices Market, Revenue ($m), 2008-2015
Table 20: Medical Device Market, UAE, Orthopedic Devices Market, Sales Trend for Major Players, 2015
Table 21: Medical Device Market, UAE, Drug Delivery Devices Market, Revenue ($m), 2008-2015
Table 22: Medical Device Market, UAE, Drug Delivery Devices Market, Sales Trend for Major Players, 2012
Table 23: Medical Device Market, UAE, Wound Care Management, Revenue ($m), 2008-2015
Table 24: Medical Device Market, UAE Wound Care Management, Sales Trends for Major Players - , 2012
Table 25: Medical Device Market, UAE, Major Medical Device Companies, Revenue, 2012
Table 26: Medical Device Market, Medtronic, Global, Major Products, Revenue ($bn), 2015
Table 27: Siemens Healthcare, Global, Major Products, 2015
Table 28: Roche, Global, Major Products, 2016
Table 29: Medical Device Market, Roche, Global, Late-Stage Pipeline, 2016
Table 30: Abbott Laboratories, Global, Major Products, 2016
Table 31: Medical Device Market, Boston Scientific, Global, Major Products, Revenue ($bn), 2016
Table 32: Market Access, UAE, Patient Share of Healthcare Expenditure (%), 2008-2014
Table 33: Market Access, UAE, Healthcare Inflation (%), 2009-2015
Table 34: Economic Indicators, UAE, Gross Domestic Product per Capita ($), 2008-2015
Table 35: Economic Indicators, UAE, Gross Domestic Product per Capita ($), Forecast, 2016-2020
Table 36: Economic Indicators, UAE, Gross Domestic Product Annual Growth (%), 2008-2015
Table 37: Economic Indicators, UAE, Gross Domestic Product Annual Growth (%), 2016-2020
Table 38: Economic Indicators, UAE, Gross National Income per Capita ($), 2008-2015
Table 39: Economic Indicators, UAE, Average Consumer Price Index, 2008-2015
Table 40: Economic Indicators, UAE, Average Consumer Price Index, Annual Change (%), 2008-2015
Table 41: Economic Indicators, UAE, Currency Exchange Rate (AED/$), 2008-2015
Table 42: Economic Indicators, UAE, Foreign Direct Investment ($bn), 2008-2015
Table 43: Economic Indicators, UAE, Foreign Exchange Reserves ($bn), 2008-2015
Table 44: Economic Indicators, UAE, Imports of Goods and Services ($bn), 2008-2015
Table 45: Economic Indicators, UAE, Exports of Goods and Services ($bn), 2008-2015
Table 46: Economic Indicators, UAE, General Government Net Debt ($bn), 2008-2015
Table 47: Economic Indicators, UAE, Major Industries by Gross Domestic Product (%), 2014 and 2015
Table 48: Demographics, UAE, Population (million), 2008-2015
Table 49: Demographics, UAE, Population (million), 2016-2020
Table 50: Demographics, UAE, Urban-Rural Population Share (%), 2008-2015
Table 51: Demographics, UAE, Urban-Rural Population Share (%),2016-2020
Table 52: Demographics, UAE, Population Distribution by Age Group (%), 2008-2015
Table 53: Demographics, UAE, Population Distribution by Age Group (%), 2016-2020
Table 54: Demographics, UAE Births (per 1,000 Population), 2008-2014
Table 55: Demographics, UAE, Mortality (per 1,000 population), 2008-2014
Table 56: Demographics, UAE, Major Causes of Mortality (Registered Deaths), 2012
Table 57: Demographics, UAE, Children <5 Mortality Rate (per 1,000 Live Births), 2008-2015
Table 58: Demographics, UAE, Immunization Rate (%), 2008-2014
Table 59: Demographics, UAE, Major Causes of Male Mortality (Registered Deaths), 2012
Table 60: Demographics, UAE, Major Causes of Female Mortality, 2012
Table 61: Demographics, UAE, Gender Ratio (M/F), 2008-2015
Table 62: Demographics, UAE, Life Expectancy at Birth (years), 2008-2015
Table 63: Demographics, UAE, Life Expectancy at Birth (years), 2016-2020
Table 64: Demographics, UAE, Levels of Higher Education, Student Enrollment, 2014
Table 65: Demographics, UAE, Graduate Education, Student Enrollment, 2014
Table 66: Demographics, UAE, Unemployment (%), 2008-2015
Table 67: Demographics, UAE, Major Diseases (number of cases), 2012
Table 68: Demographics, UAE, Disability-Adjusted Life Years (per 1,000 population), 2012
Table 69: Healthcare Infrastructure, UAE, Number of Hospitals, 2008-2014
Table 70: Healthcare Infrastructure, UAE, Public and Private Hospitals, 2008-2014
Table 71: Healthcare Infrastructure, UAE, Beds by Specialty, 2013
Table 72: Healthcare Infrastructure, UAE, Diagnostic Facilities by Ownership, 2008
Table 73: Healthcare Infrastructure, UAE, Diagnostic Facilities by Ownership, 2008
Table 74: Healthcare Infrastructure, UAE, Beds (per 100,000 population), 2008-2014
Table 75: Healthcare Infrastructure, UAE, Doctors (per 100,000 population), 2008-2014
Table 76: Environmental Health, UAE, CO2 Emissions (million metric tons), 2008-2014
Table 77: Environmental Health, UAE, PM2.5 Emissions (µg per m3), 2008-2014
Table 78: Environmental Health, UAE, Distribution of Treated Wastewater by Emirate (%), 2014
Table 79: Environmental Health, UAE, Non-hazardous Waste Handling (%), 2014
Table 80: Environmental Health, UAE, Hazardous Waste Handling (%), 2014
Table 81: Healthcare Personnel, UAE, Nurses (per 100,000 population), 2008-2014
Table 82: Healthcare Personnel, UAE, Dentists (per 100,000 population), 2008-2014
Table 83: Healthcare Expenditure, UAE, Healthcare Expenditure as a Percentage of GDP (%), 2008-2014
Table 84: Healthcare Expenditure, UAE, Major Components (%), 2014
Table 85: Healthcare Expenditure, UAE, Distribution (%), 2008-2014
Table 86: Trade Fairs, UAE, Major Healthcare Trade Fairs, 2016-2017
1.2 List of Figures
Figure 1: Pharmaceutical Market, UAE, Revenue ($bn), 2008-2015
Figure 2: Pharmaceutical Market, UAE, Revenue Forecast ($bn), 2016-2020
Figure 3: Pharmaceutical Market, UAE, Imports and Exports ($m), 2008-2014
Figure 4: Medical Device Market, UAE, Revenue ($m), 2008-2015
Figure 5: Medical Device Market, UAE, Revenue ($m), 2016-2020
Figure 6: Medical Device Market, UAE, Revenue by Segment ($m), 2015
Figure 7: Medical Device Market, UAE, In Vitro Diagnostics Market, Revenue ($m), 2008-2015
Figure 8: Medical Device Market, UAE, In Vitro Diagnostics Market, Sales Trend for Major Players (%), 2012
Figure 9: Medical Device Market, UAE, Ophthalmic Devices Market, Revenue ($m), 2008-2015
Figure 10: Medical Device Market, UAE, Ophthalmic Devices Market, Sales Trend for Major Players (%), 2012
Figure 11: Medical Device Market, UAE, Orthopedic Devices Market, Revenue ($m), 2008-2015
Figure 12: Medical Device Market, UAE, Orthopedic Devices Market, Sales Trend for Major Players (%), 2015
Figure 13: Medical Device Market, UAE, Drug Delivery Devices Market, Revenue ($m), 2008-2015
Figure 14: Medical Device Market, UAE, Drug Delivery Devices Market, Sales Trend for Major Players (%), 2012
Figure 15: Medical Device Market, UAE, Wound Care Management, Revenue ($m), 2008-2015
Figure 16: Medical Device Market, UAE, Wound Care Management, Sales Trends for Major Players - (%), 2012
Figure 17: Medical Device Market, UAE, Major Medical Device Companies, Revenue ($m), 2012
Figure 18: Healthcare Market, UAE, Drivers and Barriers, 2014
Figure 19: Market Access, UAE, Drug Formulary Procedure, 2014
Figure 20: Market Access, UAE, Patient Share of Healthcare Expenditure (%), 2008-2014
Figure 21: Market Access, UAE, Healthcare Inflation (%), 2009-2015
Figure 22: Market Access, UAE, Structure of Ministry of Health, 2016
Figure 23: Market Access, UAE, Structure of the Health Authority Abu-Dhabi, 2016
Figure 24: Market Access, UAE, New Drug Market Authorization Process, 2016
Figure 25: Market Access, UAE, Medical Device Approval Process, 2014
Figure 26: Market Access, UAE, Patent Approval Process, 2014
Figure 27: Market Access, UAE, Clinical Trial Regulation Process, 2014
Figure 28: Economic Indicators, UAE, Gross Domestic Product per Capita ($), 2008-2015
Figure 29: Economic Indicators, UAE, Gross Domestic Product per Capita ($),2016-2020
Figure 30: Economic Indicators, UAE, Gross Domestic Product Annual Growth (%), 2008-2015
Figure 31: Economic Indicators, UAE, Gross Domestic Product Annual Growth (%),2016-2020
Figure 32: Economic Indicators, UAE, Gross National Income per Capita ($), 2008-2015
Figure 33: Economic Indicators, UAE, Consumer Price Index, 2008-2015
Figure 34: Economic Indicators, UAE, Average Consumer Price Index, Annual Change (%), 2008-2015
Figure 35: Economic Indicators, UAE, Currency Exchange Rate (AED/$), 2008-2015
Figure 36: Economic Indicators, UAE, Foreign Direct Investment ($bn), 2008-2015
Figure 37: Economic Indicators, UAE, Foreign Exchange Reserves ($bn), 2008-2015
Figure 38: Economic Indicators, UAE, Imports of Goods and Services ($bn), 2008-2015
Figure 39: Economic Indicators, UAE, Exports of Goods and Services ($bn), 2008-2015
Figure 40: Economic Indicators, UAE, General Government Net Debt ($bn), 2008-2015
Figure 41: Economic Indicators, UAE, Major Industries by Gross Domestic Product (%), 2014 and 2015
Figure 42: Demographics, UAE, Population (million), 2008-2015
Figure 43: Demographics, UAE, Population (million), Forecast, 2016-2020
Figure 44: Demographics, UAE, Urban-Rural Population Share (%), 2008-2015
Figure 45: Demographics, UAE, Urban-Rural Population Share (%), 2016-2020
Figure 46: Demographics, UAE, Population Distribution by Age Group (%), 2008-2015
Figure 47: Demographics, UAE, Population Distribution by Age Group (%), 2016-2020
Figure 48: Demographics, UAE, Births (per 1,000 Population), 2008-2014
Figure 49: Demographics, UAE, Mortality (per 1,000 population), 2008-2014
Figure 50: Demographics, UAE, Major Causes of Mortality (registered deaths), 2012
Figure 51: Demographics, UAE, Children <5 Mortality Rate (per 1,000 Live Births), 2008-2015
Figure 52: Demographics, UAE, Immunization Rate (%), 2008-2014
Figure 53: Demographics, UAE, Major Causes of Male Mortality (Registered Deaths), 2012
Figure 54: Demographics, UAE, Major Causes of Female Mortality (Registered Deaths), 2012
Figure 55: Demographics, UAE, Gender Ratio (M/F), 2008-2015
Figure 56: Demographics, UAE, Life Expectancy at Birth (years), 2008-2015
Figure 57: Demographics, UAE, Life Expectancy at Birth (years), 2016-2020
Figure 58: Demographics, UAE, Levels of Higher Education, Student Enrolment, 2014
Figure 59: Demographics, UAE, Graduate Education, Student Enrollment, 2014
Figure 60: Demographics, UAE, Unemployment (%), 2008-2015
Figure 61: Demographics, UAE, Major Diseases (number of cases), 2012
Figure 62: Demographics, UAE, Disability-Adjusted Life Years (per 1,000 population), 2012
Figure 63: Healthcare Infrastructure, UAE, Number of Hospitals, 2008-2014
Figure 64: Healthcare Infrastructure, UAE, Public and Private Hospitals, 2008-2014
Figure 65: Healthcare Infrastructure, UAE, Beds by Specialty, 2013
Figure 66: Healthcare Infrastructure, UAE, Diagnostic Facilities by Ownership, 2008
Figure 67: Healthcare Infrastructure, Diagnostic Facilities by Ownership, 2008
Figure 68: Healthcare Infrastructure, UAE, Beds (per 100,000 population), 2008-2013
Figure 69: Healthcare Infrastructure, UAE, Doctors (per 100,000 population), 2008-2014
Figure 70: Environmental Health, UAE, CO2 Emissions (million metric tons), 2008-2014
Figure 71: Environmental Health, UAE, PM2.5 Emissions (µg per m3), 2008-2014
Figure 72: Environmental Health, UAE, Distribution of Treated Wastewater by Emirate (%), 2014
Figure 73: Environmental Health, UAE, Non-hazardous Waste Handling (%), 2014
Figure 74: Environmental Health, UAE, Hazardous Waste Handling (%), 2014
Figure 75: Healthcare Personnel, UAE, Nurses (per 100,000 population), 2008-2014
Figure 76: Healthcare Personnel, UAE, Dentists (per 100,000 population), 2008-2014
Figure 77: Healthcare Expenditure, UAE, Healthcare Expenditure as a Percentage of GDP (%), 2008-2014
Figure 78: Healthcare Expenditure, UAE, Major Components (%), 2014
Figure 79: Healthcare Expenditure, UAE, Distribution (%), 2008-2014
Figure 80: Healthcare Market, UAE, Opportunities and Challenges, 2014
1.2 List of Figures
2 Introduction
2.1 Report Guidance
3 Overview of Pharmaceutical and Medical Device Markets
3.1 Pharmaceutical Market
3.1.1 Market Overview
3.1.2 Pharmaceutical Imports and Exports
3.1.3 Supply Channels
3.1.4 Market Segments
3.1.5 Major Therapeutic Areas
3.1.6 Major Players
3.2 Medical Device Market
3.2.1 Market Overview
3.2.2 Overview of the Top Five Segments
3.2.3 Major Players
3.3 Market Drivers and Barriers
3.3.1 Drivers
3.3.2 Barriers
4 Market Access
4.1 Reimbursement and Payer Landscape
4.1.1 Overview of Healthcare System
4.1.2 Reimbursement Process
4.1.3 Overview of Insurance Providers
4.1.4 Patient Share of Healthcare Expenditure
4.1.5 Healthcare Price Trends
4.1.6 Pricing Policies
4.2 Regulatory Landscape
4.2.1 Overview of Regulatory Agencies
4.2.2 Market Authorization Procedure for Pharmaceutical Products
4.2.3 New Medical Device Approval Process
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing
4.2.5 Licensing Process for Pharmaceutical Exports and Imports
4.2.6 Intellectual Property Rights
4.2.7 Clinical Trial Regulations
4.2.8 Pharmaceutical Advertising Regulations
4.2.9 Pharmacy Regulations
4.2.10 Labeling and Packaging Regulations
5 Country Analysis
5.1 Political Environment
5.1.1 Political Structure
5.1.2 Analysis of the Current Political Environment
5.1.3 Healthcare Policy Initiatives
5.2 Economic Landscape
5.3 Economic Indicators
5.3.1 Gross Domestic Product
5.3.2 Gross National Income
5.3.3 Inflation
5.3.4 Currency Exchange Rate
5.3.5 Foreign Direct Investment
5.3.6 Foreign Exchange Reserves
5.3.7 Trade Balance
5.3.8 Government Net Debt
5.3.9 Major Industries
5.4 Demographics
5.4.1 Population
5.4.2 Education and Literacy
5.4.3 Employment
5.4.4 Disease Burden
5.5 Healthcare Infrastructure
5.5.1 Healthcare Facilities
5.5.2 Healthcare Parameters
5.5.3 Environmental Health
5.5.4 Healthcare Personnel
5.6 Healthcare Expenditure
5.6.1 Overview of Healthcare Expenditure
5.6.2 Major Components of Healthcare Expenditure
5.6.3 Public and Private Sector Share
5.6.4 Spending in Pharmaceutical R&D
5.7 Trade Associations
5.7.1 Arab Union of Producers of Drugs and Medical Supplies
5.7.2 Emirates Medical Association
5.7.3 Pharmaceutical Research and Manufacturers Association Gulf
5.7.4 Gulf Pharmaceutical Industries Association
5.7.5 Middle East Medical Devices and Diagnostics Trade Association
5.8 Trade Fairs
6 Opportunities and Challenges
6.1 Opportunities
6.2 Challenges
7 Appendix
7.1 Abbreviations
7.2 Bibliography
7.3 Research Methodology
7.3.1 Coverage
7.3.2 Secondary Research
7.3.3 Forecasts
7.3.4 Expert Panel
7.4 Disclaimer
1.1 List of Tables
Table 1: Pharmaceutical Market, UAE, Revenue ($bn), 2008-2015
Table 2: Pharmaceutical Market, UAE, Revenue Forecast ($bn), 2016-2020
Table 3: Pharmaceutical Market, UAE, Imports and Exports ($m), 2008-2014
Table 4: Pharmaceutical Market, Julphar, Global, Major Products, 2016
Table 5: Pharmaceutical Market, Neopharma, Global, Major Products, 2016
Table 6: Pfizer, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015
Table 7: Pharmaceutical Market, Pfizer, Late-Stage Pipeline, 2016
Table 8: GlaxoSmithKline, Global, Major Products Revenue ($m) and Annual Growth (%), 2015
Table 9: Pharmaceutical Market, GlaxoSmithKline, Late-Stage Pipeline, 2016
Table 10: Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015
Table 11: Pharmaceutical Market, Novartis, Planned Filings, 2014-2018
Table 12: Medical Device Market, UAE, Revenue ($m), 2008-2015
Table 13: Medical Device Market, UAE, Revenue ($m), 2016-2020
Table 14: Medical Device Market, UAE, Revenue by Segment ($m), 2015
Table 15: Medical Device Market, UAE, In Vitro Diagnostics Market, Revenue ($m), 2008-2015
Table 16: Medical Device Market, UAE, In Vitro Diagnostics Market, Sales Trend for Major Players, 2012
Table 17: Medical Device Market, UAE, Ophthalmic Devices Market, Revenue ($m), 2008-2015
Table 18: Medical Device Market, UAE, Ophthalmic Devices Market, Sales Trend for Major Players, 2012
Table 19: Medical Device Market, UAE, Orthopedic Devices Market, Revenue ($m), 2008-2015
Table 20: Medical Device Market, UAE, Orthopedic Devices Market, Sales Trend for Major Players, 2015
Table 21: Medical Device Market, UAE, Drug Delivery Devices Market, Revenue ($m), 2008-2015
Table 22: Medical Device Market, UAE, Drug Delivery Devices Market, Sales Trend for Major Players, 2012
Table 23: Medical Device Market, UAE, Wound Care Management, Revenue ($m), 2008-2015
Table 24: Medical Device Market, UAE Wound Care Management, Sales Trends for Major Players - , 2012
Table 25: Medical Device Market, UAE, Major Medical Device Companies, Revenue, 2012
Table 26: Medical Device Market, Medtronic, Global, Major Products, Revenue ($bn), 2015
Table 27: Siemens Healthcare, Global, Major Products, 2015
Table 28: Roche, Global, Major Products, 2016
Table 29: Medical Device Market, Roche, Global, Late-Stage Pipeline, 2016
Table 30: Abbott Laboratories, Global, Major Products, 2016
Table 31: Medical Device Market, Boston Scientific, Global, Major Products, Revenue ($bn), 2016
Table 32: Market Access, UAE, Patient Share of Healthcare Expenditure (%), 2008-2014
Table 33: Market Access, UAE, Healthcare Inflation (%), 2009-2015
Table 34: Economic Indicators, UAE, Gross Domestic Product per Capita ($), 2008-2015
Table 35: Economic Indicators, UAE, Gross Domestic Product per Capita ($), Forecast, 2016-2020
Table 36: Economic Indicators, UAE, Gross Domestic Product Annual Growth (%), 2008-2015
Table 37: Economic Indicators, UAE, Gross Domestic Product Annual Growth (%), 2016-2020
Table 38: Economic Indicators, UAE, Gross National Income per Capita ($), 2008-2015
Table 39: Economic Indicators, UAE, Average Consumer Price Index, 2008-2015
Table 40: Economic Indicators, UAE, Average Consumer Price Index, Annual Change (%), 2008-2015
Table 41: Economic Indicators, UAE, Currency Exchange Rate (AED/$), 2008-2015
Table 42: Economic Indicators, UAE, Foreign Direct Investment ($bn), 2008-2015
Table 43: Economic Indicators, UAE, Foreign Exchange Reserves ($bn), 2008-2015
Table 44: Economic Indicators, UAE, Imports of Goods and Services ($bn), 2008-2015
Table 45: Economic Indicators, UAE, Exports of Goods and Services ($bn), 2008-2015
Table 46: Economic Indicators, UAE, General Government Net Debt ($bn), 2008-2015
Table 47: Economic Indicators, UAE, Major Industries by Gross Domestic Product (%), 2014 and 2015
Table 48: Demographics, UAE, Population (million), 2008-2015
Table 49: Demographics, UAE, Population (million), 2016-2020
Table 50: Demographics, UAE, Urban-Rural Population Share (%), 2008-2015
Table 51: Demographics, UAE, Urban-Rural Population Share (%),2016-2020
Table 52: Demographics, UAE, Population Distribution by Age Group (%), 2008-2015
Table 53: Demographics, UAE, Population Distribution by Age Group (%), 2016-2020
Table 54: Demographics, UAE Births (per 1,000 Population), 2008-2014
Table 55: Demographics, UAE, Mortality (per 1,000 population), 2008-2014
Table 56: Demographics, UAE, Major Causes of Mortality (Registered Deaths), 2012
Table 57: Demographics, UAE, Children <5 Mortality Rate (per 1,000 Live Births), 2008-2015
Table 58: Demographics, UAE, Immunization Rate (%), 2008-2014
Table 59: Demographics, UAE, Major Causes of Male Mortality (Registered Deaths), 2012
Table 60: Demographics, UAE, Major Causes of Female Mortality, 2012
Table 61: Demographics, UAE, Gender Ratio (M/F), 2008-2015
Table 62: Demographics, UAE, Life Expectancy at Birth (years), 2008-2015
Table 63: Demographics, UAE, Life Expectancy at Birth (years), 2016-2020
Table 64: Demographics, UAE, Levels of Higher Education, Student Enrollment, 2014
Table 65: Demographics, UAE, Graduate Education, Student Enrollment, 2014
Table 66: Demographics, UAE, Unemployment (%), 2008-2015
Table 67: Demographics, UAE, Major Diseases (number of cases), 2012
Table 68: Demographics, UAE, Disability-Adjusted Life Years (per 1,000 population), 2012
Table 69: Healthcare Infrastructure, UAE, Number of Hospitals, 2008-2014
Table 70: Healthcare Infrastructure, UAE, Public and Private Hospitals, 2008-2014
Table 71: Healthcare Infrastructure, UAE, Beds by Specialty, 2013
Table 72: Healthcare Infrastructure, UAE, Diagnostic Facilities by Ownership, 2008
Table 73: Healthcare Infrastructure, UAE, Diagnostic Facilities by Ownership, 2008
Table 74: Healthcare Infrastructure, UAE, Beds (per 100,000 population), 2008-2014
Table 75: Healthcare Infrastructure, UAE, Doctors (per 100,000 population), 2008-2014
Table 76: Environmental Health, UAE, CO2 Emissions (million metric tons), 2008-2014
Table 77: Environmental Health, UAE, PM2.5 Emissions (µg per m3), 2008-2014
Table 78: Environmental Health, UAE, Distribution of Treated Wastewater by Emirate (%), 2014
Table 79: Environmental Health, UAE, Non-hazardous Waste Handling (%), 2014
Table 80: Environmental Health, UAE, Hazardous Waste Handling (%), 2014
Table 81: Healthcare Personnel, UAE, Nurses (per 100,000 population), 2008-2014
Table 82: Healthcare Personnel, UAE, Dentists (per 100,000 population), 2008-2014
Table 83: Healthcare Expenditure, UAE, Healthcare Expenditure as a Percentage of GDP (%), 2008-2014
Table 84: Healthcare Expenditure, UAE, Major Components (%), 2014
Table 85: Healthcare Expenditure, UAE, Distribution (%), 2008-2014
Table 86: Trade Fairs, UAE, Major Healthcare Trade Fairs, 2016-2017
1.2 List of Figures
Figure 1: Pharmaceutical Market, UAE, Revenue ($bn), 2008-2015
Figure 2: Pharmaceutical Market, UAE, Revenue Forecast ($bn), 2016-2020
Figure 3: Pharmaceutical Market, UAE, Imports and Exports ($m), 2008-2014
Figure 4: Medical Device Market, UAE, Revenue ($m), 2008-2015
Figure 5: Medical Device Market, UAE, Revenue ($m), 2016-2020
Figure 6: Medical Device Market, UAE, Revenue by Segment ($m), 2015
Figure 7: Medical Device Market, UAE, In Vitro Diagnostics Market, Revenue ($m), 2008-2015
Figure 8: Medical Device Market, UAE, In Vitro Diagnostics Market, Sales Trend for Major Players (%), 2012
Figure 9: Medical Device Market, UAE, Ophthalmic Devices Market, Revenue ($m), 2008-2015
Figure 10: Medical Device Market, UAE, Ophthalmic Devices Market, Sales Trend for Major Players (%), 2012
Figure 11: Medical Device Market, UAE, Orthopedic Devices Market, Revenue ($m), 2008-2015
Figure 12: Medical Device Market, UAE, Orthopedic Devices Market, Sales Trend for Major Players (%), 2015
Figure 13: Medical Device Market, UAE, Drug Delivery Devices Market, Revenue ($m), 2008-2015
Figure 14: Medical Device Market, UAE, Drug Delivery Devices Market, Sales Trend for Major Players (%), 2012
Figure 15: Medical Device Market, UAE, Wound Care Management, Revenue ($m), 2008-2015
Figure 16: Medical Device Market, UAE, Wound Care Management, Sales Trends for Major Players - (%), 2012
Figure 17: Medical Device Market, UAE, Major Medical Device Companies, Revenue ($m), 2012
Figure 18: Healthcare Market, UAE, Drivers and Barriers, 2014
Figure 19: Market Access, UAE, Drug Formulary Procedure, 2014
Figure 20: Market Access, UAE, Patient Share of Healthcare Expenditure (%), 2008-2014
Figure 21: Market Access, UAE, Healthcare Inflation (%), 2009-2015
Figure 22: Market Access, UAE, Structure of Ministry of Health, 2016
Figure 23: Market Access, UAE, Structure of the Health Authority Abu-Dhabi, 2016
Figure 24: Market Access, UAE, New Drug Market Authorization Process, 2016
Figure 25: Market Access, UAE, Medical Device Approval Process, 2014
Figure 26: Market Access, UAE, Patent Approval Process, 2014
Figure 27: Market Access, UAE, Clinical Trial Regulation Process, 2014
Figure 28: Economic Indicators, UAE, Gross Domestic Product per Capita ($), 2008-2015
Figure 29: Economic Indicators, UAE, Gross Domestic Product per Capita ($),2016-2020
Figure 30: Economic Indicators, UAE, Gross Domestic Product Annual Growth (%), 2008-2015
Figure 31: Economic Indicators, UAE, Gross Domestic Product Annual Growth (%),2016-2020
Figure 32: Economic Indicators, UAE, Gross National Income per Capita ($), 2008-2015
Figure 33: Economic Indicators, UAE, Consumer Price Index, 2008-2015
Figure 34: Economic Indicators, UAE, Average Consumer Price Index, Annual Change (%), 2008-2015
Figure 35: Economic Indicators, UAE, Currency Exchange Rate (AED/$), 2008-2015
Figure 36: Economic Indicators, UAE, Foreign Direct Investment ($bn), 2008-2015
Figure 37: Economic Indicators, UAE, Foreign Exchange Reserves ($bn), 2008-2015
Figure 38: Economic Indicators, UAE, Imports of Goods and Services ($bn), 2008-2015
Figure 39: Economic Indicators, UAE, Exports of Goods and Services ($bn), 2008-2015
Figure 40: Economic Indicators, UAE, General Government Net Debt ($bn), 2008-2015
Figure 41: Economic Indicators, UAE, Major Industries by Gross Domestic Product (%), 2014 and 2015
Figure 42: Demographics, UAE, Population (million), 2008-2015
Figure 43: Demographics, UAE, Population (million), Forecast, 2016-2020
Figure 44: Demographics, UAE, Urban-Rural Population Share (%), 2008-2015
Figure 45: Demographics, UAE, Urban-Rural Population Share (%), 2016-2020
Figure 46: Demographics, UAE, Population Distribution by Age Group (%), 2008-2015
Figure 47: Demographics, UAE, Population Distribution by Age Group (%), 2016-2020
Figure 48: Demographics, UAE, Births (per 1,000 Population), 2008-2014
Figure 49: Demographics, UAE, Mortality (per 1,000 population), 2008-2014
Figure 50: Demographics, UAE, Major Causes of Mortality (registered deaths), 2012
Figure 51: Demographics, UAE, Children <5 Mortality Rate (per 1,000 Live Births), 2008-2015
Figure 52: Demographics, UAE, Immunization Rate (%), 2008-2014
Figure 53: Demographics, UAE, Major Causes of Male Mortality (Registered Deaths), 2012
Figure 54: Demographics, UAE, Major Causes of Female Mortality (Registered Deaths), 2012
Figure 55: Demographics, UAE, Gender Ratio (M/F), 2008-2015
Figure 56: Demographics, UAE, Life Expectancy at Birth (years), 2008-2015
Figure 57: Demographics, UAE, Life Expectancy at Birth (years), 2016-2020
Figure 58: Demographics, UAE, Levels of Higher Education, Student Enrolment, 2014
Figure 59: Demographics, UAE, Graduate Education, Student Enrollment, 2014
Figure 60: Demographics, UAE, Unemployment (%), 2008-2015
Figure 61: Demographics, UAE, Major Diseases (number of cases), 2012
Figure 62: Demographics, UAE, Disability-Adjusted Life Years (per 1,000 population), 2012
Figure 63: Healthcare Infrastructure, UAE, Number of Hospitals, 2008-2014
Figure 64: Healthcare Infrastructure, UAE, Public and Private Hospitals, 2008-2014
Figure 65: Healthcare Infrastructure, UAE, Beds by Specialty, 2013
Figure 66: Healthcare Infrastructure, UAE, Diagnostic Facilities by Ownership, 2008
Figure 67: Healthcare Infrastructure, Diagnostic Facilities by Ownership, 2008
Figure 68: Healthcare Infrastructure, UAE, Beds (per 100,000 population), 2008-2013
Figure 69: Healthcare Infrastructure, UAE, Doctors (per 100,000 population), 2008-2014
Figure 70: Environmental Health, UAE, CO2 Emissions (million metric tons), 2008-2014
Figure 71: Environmental Health, UAE, PM2.5 Emissions (µg per m3), 2008-2014
Figure 72: Environmental Health, UAE, Distribution of Treated Wastewater by Emirate (%), 2014
Figure 73: Environmental Health, UAE, Non-hazardous Waste Handling (%), 2014
Figure 74: Environmental Health, UAE, Hazardous Waste Handling (%), 2014
Figure 75: Healthcare Personnel, UAE, Nurses (per 100,000 population), 2008-2014
Figure 76: Healthcare Personnel, UAE, Dentists (per 100,000 population), 2008-2014
Figure 77: Healthcare Expenditure, UAE, Healthcare Expenditure as a Percentage of GDP (%), 2008-2014
Figure 78: Healthcare Expenditure, UAE, Major Components (%), 2014
Figure 79: Healthcare Expenditure, UAE, Distribution (%), 2008-2014
Figure 80: Healthcare Market, UAE, Opportunities and Challenges, 2014
Note: Product cover images may vary from those shown
3 of 5
LOADING...
4 of 5
The UAE's healthcare market has significant potential for growth, driven by an increasing burden of lifestyle-related diseases, medical tourism, straightforward regulatory guidelines and a preference for branded imported products. However, factors such as frequent price cuts by the government and usage of counterfeit drugs will restrict the growth of the pharmaceutical market.
The UAE is the second largest country in the Middle East in terms of capital invested in the pharmaceutical sector. In 2013, the UAE's pharmaceutical market was estimated to be worth $2.4 billion, having increased from $1.3 billion in 2008 at a Compound Annual Growth Rate (CAGR) of 12.6%. The market is expected to reach $3.7 billion in 2020 at a CAGR of 5.3% (Kulkarni, 2010). Increased healthcare expenditure, the growing popularity of medical tourism and a growing elderly population are the main contributors to market growth.
Due to its growing healthcare infrastructure and lower treatment costs compared to competitors, the UAE is quickly gaining popularity as a medical tourism destination due to its low costs, English-speaking medical staff and virtually non-existent queues for treatment (Woodman, 2012). Dubai Health Authority is working to develop the medical tourism sector. It is formulating different healthcare packages according to patient requirements and the first package (wellness and preventive services package) is to be launched in October 2014 (UAEinteract, 2014f).
Branded imported drugs dominate the pharmaceutical market, with approximately 80% of the market share. Therapeutic segments such as cardiovascular diseases and cancer are expected to grow significantly in the coming years due to the growing incidence of certain lifestyle diseases. Multinational companies will continue to penetrate the market as they offer largely patented drugs, whereas a lack of R&D activities from domestic manufacturers has limited their ability to offer patented drugs.
The UAE government has been reducing the prices of drugs since 2011 to make them more affordable for people as the prices of pharmaceutical medicines were comparatively much higher than in other neighboring GCC countries. Since 2011, the Ministry of Health (MoH) has reduced the prices of medicines five times, by percentages ranging from 1% to 60% (Sophia, 2014; Zain, 2014).
The proliferation of counterfeit drugs in the UAE is very high. According to a 2010 European Commission report, 73% of the drugs seized in the European Union (EU) were routed through the UAE (Underwood, 2010). These factors hamper the pharmaceutical market in the UAE.
In 2008, the UAE's medical device market was valued at approximately $600.2m and $733.3m in 2013. The medical device market is estimated to reach $978.9m in 2020, at a CAGR of 4.2% from 2014, mainly due to positive demographics, increased healthcare awareness and a rise in healthcare spending. The significant demand for medical devices in the UAE is met through imports.
In an attempt to prevent age-related chronic diseases and lifestyle diseases, the government has implemented the national Weqaya program and set up various specialty healthcare facilities.
The UAE is the second largest country in the Middle East in terms of capital invested in the pharmaceutical sector. In 2013, the UAE's pharmaceutical market was estimated to be worth $2.4 billion, having increased from $1.3 billion in 2008 at a Compound Annual Growth Rate (CAGR) of 12.6%. The market is expected to reach $3.7 billion in 2020 at a CAGR of 5.3% (Kulkarni, 2010). Increased healthcare expenditure, the growing popularity of medical tourism and a growing elderly population are the main contributors to market growth.
Due to its growing healthcare infrastructure and lower treatment costs compared to competitors, the UAE is quickly gaining popularity as a medical tourism destination due to its low costs, English-speaking medical staff and virtually non-existent queues for treatment (Woodman, 2012). Dubai Health Authority is working to develop the medical tourism sector. It is formulating different healthcare packages according to patient requirements and the first package (wellness and preventive services package) is to be launched in October 2014 (UAEinteract, 2014f).
Branded imported drugs dominate the pharmaceutical market, with approximately 80% of the market share. Therapeutic segments such as cardiovascular diseases and cancer are expected to grow significantly in the coming years due to the growing incidence of certain lifestyle diseases. Multinational companies will continue to penetrate the market as they offer largely patented drugs, whereas a lack of R&D activities from domestic manufacturers has limited their ability to offer patented drugs.
The UAE government has been reducing the prices of drugs since 2011 to make them more affordable for people as the prices of pharmaceutical medicines were comparatively much higher than in other neighboring GCC countries. Since 2011, the Ministry of Health (MoH) has reduced the prices of medicines five times, by percentages ranging from 1% to 60% (Sophia, 2014; Zain, 2014).
The proliferation of counterfeit drugs in the UAE is very high. According to a 2010 European Commission report, 73% of the drugs seized in the European Union (EU) were routed through the UAE (Underwood, 2010). These factors hamper the pharmaceutical market in the UAE.
In 2008, the UAE's medical device market was valued at approximately $600.2m and $733.3m in 2013. The medical device market is estimated to reach $978.9m in 2020, at a CAGR of 4.2% from 2014, mainly due to positive demographics, increased healthcare awareness and a rise in healthcare spending. The significant demand for medical devices in the UAE is met through imports.
In an attempt to prevent age-related chronic diseases and lifestyle diseases, the government has implemented the national Weqaya program and set up various specialty healthcare facilities.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
